AzzouzMRømsingJThomsenHS. Acute non-renal adverse events after unenhanced and enhanced computed tomography and magnetic resonance imaging. Open J Clin Diagn2013; 3: 85–93.
2.
ThomsenHSWebbJAW. The Lalli and Weber effects and the incidence of acute non-renal adverse reactions to contrast media. Acta Radiol2012; 53: 953–954.
3.
ESUR Contrast Media Safety Committee. ESUR guidelines on contrast media version 9.0. Available at: www.esur2015.org.
4.
AzzouzMRømsingJThomsenHS. Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients. Eur J Radiol2014; 83: 886–892.
5.
RaoQNewhouseJH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology2006; 239: 392–397.
6.
CramerBCParfreyPSHutchinsonTA. Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med1985; 145: 87–89.
7.
HellerCAKnappJHallidayJ. Failure to demonstrate contrast nephrotoxicity. Med J Aust1991; 155: 329–332.
8.
McDonaldJSMcDonaldRJCominJ. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology2013; 267: 119–128.
DavenportMSKhalatbariSCohanRH. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology2013; 268: 719–728.
12.
McDonaldRJMcDonaldJSNewhouseJH. Controversies in contrast material-induced acute kidney injury: Closing in on the truth?Radiology2015; 277: 627–632.
13.
NymanUAspelinPJakobsenJ. Controversies in contrast material-induced acute kidney injury: Propensity score matching of patients with different score matching of patients with different dose/absolute glomerular filtration rate ratios. Radiology2015; 277: 633–637.
